Ascent Group’s CARGO Therapeutics CRGX Stock Holding History

Ascent Group’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,665	Closed	-$43.4K	–	726
2025 Q1	$43.4K	Buy	+10,665	New	+$71.4K	﹤0.01%	691

Other funds holding CRGX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGV

TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

TGV

TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

Ascent Group's CRGX Position: Q2 2025 in Review

Ascent Group sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 10,665 shares — an estimated $43.4K sold.

Ascent Group first reported a position in CRGX in Q1 2025 and held it in 1 quarter. The position peaked at $43.4K in Q1 2025. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

Ascent Group reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
Ascent Group sold 10,665 CARGO Therapeutics shares in Q2 2025, an estimated $43.4K.
Ascent Group first reported a position in CARGO Therapeutics in Q1 2025 and held it in 1 quarter.
Ascent Group's CARGO Therapeutics position peaked at $43.4K in Q1 2025.
116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on Ascent Group's 13F filing for Q2 2025, filed 21 Jul 2025.